Page 283 - PROGRAMME2018

P-509 A follow-up survey on the reproductive intentions and experiences of women who underwent “social freezing” or elective oocyte cryopreservation
A. Wafi1, J. Nekkebroeck1, C. Blockeel1, N. De Munck1, H. Tournaye1, M. De Vos1
1Universitair Ziekenhuis Brussel- Vrije Universiteit Brussel- Brussel- Belgium., Centre for Reproductive Medicine, Brussel, Belgium
P-510 Professionals’ barriers in female oncofertility care and strategies for improvement
M. Van den Berg1, Ö. Baysal1, I. Beerendonk1, D. Braat1, W. Nelen1, R. Hermens2
1Radboud University Medical Centre, Obstetrics and Gynaecology, Nijmegen, The Netherlands 2Radboud University Medical Centre, IQ Healthcare, Nijmegen, The Netherlands
P-511 IVM before vitrification induces alterations of maturation rates and deleterious effects on actin and tubulin architecture of human oocytes
A. Metchat1, H. Pons-Rejraji1, S. Vorilhon1, S. Mestres1, S. Lusho1, L. Chaput1, S. Dollet1, A.S. Grémeau1, J.L. Pouly1, F. Brugnon1
1Université Clermont Auvergne-CHU Clermont-Ferrand, Biologie de la Reproduction-AMP-CECOS, Clermont-Ferrand, France
P-512 Assessment of a sensitive and specific method to detect Ewing sarcoma minimal residual disease in testicular and ovarian tissue by RT-qPCR
L. Chaput1, V. Grèze2, P. Halle3, A. Tchirkov4, L. Véronèse4, N. Robin5, B. Pereira6, H. Lejeune7, P. Durand8, G. Martin8, A.S. Grémeau1, M. Canis1, F. Brugnon1
1CHU Clermont-Ferrand- Site Estaing, Biologie et Médecine de la Reproduction- AMP-CECOS, Clermont-Ferrand, France
2CHU Clermont-Ferrand- Site Estaing, Service d’Hématologie et d’Oncologie Pédiatrique, Clermont- Ferrand, France
3CHU Clermont-Ferrand- Site Estaing, Centre de Biothérapie d'Auvergne, Clermont-Ferrand, France 4CHU Clermont-Ferrand- Site Estaing, Service de Cytogénétique Médicale, Clermont-Ferrand, France
5Centre Jean Perrin CLCC de la région Auvergne, LBM OncoGènAuvergne- Unité Pathologie, Clermont Ferrand, France
6CHU Clermont Ferrand, Unité de Biostatistiques- Délégation à la Recherche Clinique et l'Innovation, Clermont Ferrand, France
7CHU Lyon Hôpital Femme Mère Enfant, Service de Médecine de la Reproduction, Lyon, France 8Ecole Normale Supérieure de Lyon, Kallistem, Lyon, France
P-513 Texture profile analysis reveals a stiffer ovarian cortex after testosterone therapy
C. De Roo1, K. Tilleman1, C. Vercruysse2, H. Declercq2, G. T'Sjoen3, S. Weyers1, P. De Sutter1
1University Hospital Ghent UZ, Division of Reproductive Medicine- Department of Gynaecology, Ghent, Belgium
2Ghent University, Bioprint Core Facility- Tissue Engineering and BiomaterialsDepartment of Basic Medical Science- Faculty of Medicine and Health Science, Ghent, Belgium
3Ghent University Hospital, Department of Endocrinology and Center for Sexology and Gender, Ghent, Belgium
FINAL PROGRAMME I BARCELONA, SPAIN – 1 TO 4 JULY 2018 283
POSTERS